A single-center , open-label , randomized , multiple-dose , three-treatment , three-sequence , crossover study was performed in @ healthy male subjects , aged @-@ years , who randomly received one of the following treatments for @ days in each period : itopride @ mg ER once daily under fasting or fed conditions , or itopride @ mg IR three times daily in the fasting state .